Cost Variation Analysis of Hypolipidemic Drugs Currently Available in Indian Pharmaceutical Market
42% of all fatalities worldwide resulting from non-communicable diseases (NCD) are attributable to cardiovascular illnesses. The availability of several brands and generic medications causes a wide range in the pricing at which they are sold. This study was conducted to raise awareness amon...
Saved in:
Main Authors: | Prajnyan Prasad Kalita, Hiteswar Saikia, Meghali Chaliha |
---|---|
Format: | Article |
Language: | English |
Published: |
Krupanidhi College of Pharmacy
2024-06-01
|
Series: | Journal of Pharmaceutical Research |
Online Access: | https://jopcr.com/articles/cost-variation-analysis-of-hypolipidemic-drugs-currently-available-in-indian-pharmaceutical-market |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost Analysis Study of Topical Anti-Acne Drugs Currently Available in Indian Pharmaceutical Market
by: Neelomjyoti Gohain, et al.
Published: (2024-03-01) -
Problems of pharmaceutical provision of population with hypolipidemic drugs: the case of the Volgograd region (the Russian Federation)
by: I. N. Tyurenkov, et al.
Published: (2020-05-01) -
Cost Analysis of DPP4 and SGLT2 Inhibitors - “Dilemma of the Prescribing Physician - Which Brand to Choose?”
by: Hiteswar Saikia, et al.
Published: (2024-06-01) -
Analysis of Package Inserts Available in the Indian Market
by: Alay Patel, et al.
Published: (2024-06-01) -
Analytical assessment of hypoglycemic drugs’ availability in the regional pharmaceutical market: The case of Sverdlovsk region
by: Светлана Бегичева, et al.
Published: (2025-06-01)